Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

120 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effects of ALO 2145 on intraocular pressure following argon laser trabeculoplasty.
Robin AL, Pollack IP, House B, Enger C. Robin AL, et al. Among authors: enger c. Arch Ophthalmol. 1987 May;105(5):646-50. doi: 10.1001/archopht.1987.01060050064039. Arch Ophthalmol. 1987. PMID: 2887153 Clinical Trial.
Corneal thickness changes after high-risk penetrating keratoplasty. Collaborative Corneal Transplantation Study Group.
McDonnell PJ, Enger C, Stark WJ, Stulting RD. McDonnell PJ, et al. Among authors: enger c. Arch Ophthalmol. 1993 Oct;111(10):1374-81. doi: 10.1001/archopht.1993.01090100082032. Arch Ophthalmol. 1993. PMID: 8216018 Clinical Trial.
Bone marrow transplantation and cataract development.
Dunn JP, Jabs DA, Wingard J, Enger C, Vogelsang G, Santos G. Dunn JP, et al. Among authors: enger c. Arch Ophthalmol. 1993 Oct;111(10):1367-73. doi: 10.1001/archopht.1993.01090100075031. Arch Ophthalmol. 1993. PMID: 8216017
Contrast sensitivity in age-related macular degeneration.
Kleiner RC, Enger C, Alexander MF, Fine SL. Kleiner RC, et al. Among authors: enger c. Arch Ophthalmol. 1988 Jan;106(1):55-7. doi: 10.1001/archopht.1988.01060130061028. Arch Ophthalmol. 1988. PMID: 3337707
Risk factors for the development of glaucomatous visual field loss in ocular hypertension.
Quigley HA, Enger C, Katz J, Sommer A, Scott R, Gilbert D. Quigley HA, et al. Among authors: enger c. Arch Ophthalmol. 1994 May;112(5):644-9. doi: 10.1001/archopht.1994.01090170088028. Arch Ophthalmol. 1994. PMID: 8185522
Refractive changes after scleral buckling surgery.
Smiddy WE, Loupe DN, Michels RG, Enger C, Glaser BM, deBustros S. Smiddy WE, et al. Among authors: enger c. Arch Ophthalmol. 1989 Oct;107(10):1469-71. doi: 10.1001/archopht.1989.01070020543036. Arch Ophthalmol. 1989. PMID: 2803094
Hospitalization requirements after vitreoretinal surgery.
Isernhagen RD, Michels RG, Glaser BM, de Bustros S, Enger C. Isernhagen RD, et al. Among authors: enger c. Arch Ophthalmol. 1988 Jun;106(6):767-70. doi: 10.1001/archopht.1988.01060130837035. Arch Ophthalmol. 1988. PMID: 3370003
Cytomegalovirus retinitis and acquired immunodeficiency syndrome.
Jabs DA, Enger C, Bartlett JG. Jabs DA, et al. Among authors: enger c. Arch Ophthalmol. 1989 Jan;107(1):75-80. doi: 10.1001/archopht.1989.01070010077031. Arch Ophthalmol. 1989. PMID: 2535932
Cardiovascular and intraocular pressure effects and plasma concentrations of apraclonidine.
Coleman AL, Robin AL, Pollack IP, Rudikoff MT, Enger C, Mayer PR. Coleman AL, et al. Among authors: enger c. Arch Ophthalmol. 1990 Sep;108(9):1264-7. doi: 10.1001/archopht.1990.01070110080029. Arch Ophthalmol. 1990. PMID: 2205182 Clinical Trial.
Reformulation and drop size of apraclonidine hydrochloride.
Vocci MJ, Robin AL, Wahl JC, Mayer P, Graves A, York B, Enger C, Sutton J. Vocci MJ, et al. Among authors: enger c. Am J Ophthalmol. 1992 Feb 15;113(2):154-60. doi: 10.1016/s0002-9394(14)71527-2. Am J Ophthalmol. 1992. PMID: 1347973 Clinical Trial.
120 results
Jump to page
Feedback